ICLIPSE Trademark

Trademark Overview

On Tuesday, July 13, 2021, a trademark application was filed for ICLIPSE with the United States Patent and Trademark Office. The USPTO has given the ICLIPSE trademark a serial number of 90824789. The federal status of this trademark filing is FOURTH EXTENSION - GRANTED as of Wednesday, July 3, 2024. This trademark is owned by Glaukos Corporation. The ICLIPSE trademark is filed in the Medical Instrument Products category with the following description:

Medical device for use in or in connection with the eye that allows the flow of a drug into the eye, namely, for eluting a drug onto the cornea and other surfaces and surrounding areas of the eye
iclipse

General Information

Serial Number90824789
Word MarkICLIPSE
Filing DateTuesday, July 13, 2021
Status733 - FOURTH EXTENSION - GRANTED
Status DateWednesday, July 3, 2024
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, May 10, 2022

Trademark Statements

Goods and ServicesMedical device for use in or in connection with the eye that allows the flow of a drug into the eye, namely, for eluting a drug onto the cornea and other surfaces and surrounding areas of the eye

Classification Information

International Class010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials.
US Class Codes026, 039, 044
Class Status Code6 - Active
Class Status DateFriday, September 17, 2021
Primary Code010
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History

Party NameGlaukos Corporation
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672
Party NameGlaukos Corporation
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Clemente, CA 92672

Trademark Events

Event DateEvent Description
Friday, July 16, 2021NEW APPLICATION ENTERED
Friday, September 17, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, March 31, 2022ASSIGNED TO EXAMINER
Friday, April 1, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, April 20, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, May 10, 2022PUBLISHED FOR OPPOSITION
Tuesday, May 10, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, July 5, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 15, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, November 15, 2022SOU EXTENSION 1 FILED
Tuesday, November 15, 2022SOU EXTENSION 1 GRANTED
Thursday, November 17, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, June 30, 2023SOU TEAS EXTENSION RECEIVED
Friday, June 30, 2023SOU EXTENSION 2 FILED
Friday, June 30, 2023SOU EXTENSION 2 GRANTED
Tuesday, July 4, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 14, 2023SOU TEAS EXTENSION RECEIVED
Wednesday, July 3, 2024SOU TEAS EXTENSION RECEIVED
Wednesday, July 3, 2024NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, July 3, 2024SOU EXTENSION 4 GRANTED
Wednesday, July 3, 2024SOU EXTENSION 4 FILED
Thursday, December 14, 2023SOU EXTENSION 3 FILED
Thursday, December 14, 2023SOU EXTENSION 3 GRANTED
Saturday, December 16, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Friday, February 16, 2024ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, February 16, 2024TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Friday, February 16, 2024TEAS CHANGE OF CORRESPONDENCE RECEIVED

Related Keywords

iclipse drug cornea other surfaces areas surrounding onto namely connection device